India's SENSEX30 index opened 0.07% higher at 81,568.39 points. Among the constituent stocks, ULTRATECH CEMENT opened 1% higher, Asian Coatings rose 0.74% and BAJAJ FINANCE rose 0.62%. In terms of decline, Mahengda Information Technology opened 0.44% lower, India Industrial Credit Investment Bank fell 0.33%, and HCL TECHNOLOGIES fell 0.26%.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.China Overseas Development: The annual interest of "23 Zhonghai 04" will be paid on December 12th. On December 10th, China Overseas Development (00688.HK) announced that China Overseas Enterprise Development Group Co., Ltd., a wholly-owned subsidiary of the company, will pay the annual interest of "23 Zhonghai 04" on December 12th, totaling 96 million yuan. The total amount of bonds issued in this issue is 3 billion yuan, and the issuance period is 5 years. The coupon rate of bonds in this issue is 3.20%.
Yonhap News Agency: South Korean Prime Minister Han Dezhu blamed himself for failing to stop martial law.China Minerals and Guangxi Iron and Steel have established mining technology companies. The enterprise search APP shows that recently, China National Mining Chain (Guangxi) Mining Technology Co., Ltd. was established, with Ji Wendong as the legal representative and a registered capital of 90 million yuan. Its business scope includes mineral washing and processing, metal ore sales and metal material sales. Enterprise survey shows that the company is jointly owned by China Mineral's China Mineral Resources Group International Supply Chain Co., Ltd. and Guangxi Iron and Steel Group Co., Ltd.Trader: The Indian central bank is suspected of selling dollars to limit the depreciation of Indian Rupee.
Listed companies are enthusiastic about dividends. The Standard & Poor's dividend ETF(562060) rose by 0.53% at midday, and the constituent stocks were all red. By midday on December 11th, the standard & poor's dividend ETF(562060) rose by 0.53%, with a turnover of 28,056,300 yuan. The constituent stocks were all red, Lu 'an Huaneng rose by 2.13%, Orchid Kechuang and Voice Holdings rose by nearly 2%, and Aopu Technology and Pingmei shares followed suit. In the news, Wind data shows that as of December 10th, 267 listed companies have issued dividend plans for the third quarter, and 696 listed companies have issued dividend plans for the semi-annual period. The number of dividend plans for the third quarter and semi-annual period has reached record highs. According to industry insiders, dividends of listed companies will bring certain returns to investors, enhance investors' confidence, help attract long-term funds and enhance the stability and activity of the market. To sum up, in the period of high-quality economic growth, companies with higher dividend-paying ability and willingness are expected to be more and more favored by funds, and investors can try their best to seize the long-term opportunity of dividend theme by using the standard general dividend ETF(562060).Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13